| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Tom J Brett | |
| Kayla N Berry | |||
| Daniel L Kober | |||
| Alvin Su | |||
| P2860 | cites work | Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2 | Q21559418 |
| Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin | Q24294470 | ||
| HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions | Q24296630 | ||
| Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1 | Q24297949 | ||
| Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms | Q24302747 | ||
| Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain | Q24306855 | ||
| Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction | Q24309134 | ||
| Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin | Q24318564 | ||
| A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells | Q24319113 | ||
| BST-2/tetherin: a new component of the innate immune response to enveloped viruses | Q24630382 | ||
| Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism | Q24644811 | ||
| HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes | Q24646984 | ||
| Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus | Q24650331 | ||
| Inhibition of Lassa and Marburg virus production by tetherin | Q24652263 | ||
| Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection. | Q24701738 | ||
| The role of BST-2/Tetherin in host protection and disease manifestation | Q26752737 | ||
| Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles | Q27316022 | ||
| Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells | Q27321247 | ||
| Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations | Q27664759 | ||
| Structural insight into the mechanisms of enveloped virus tethering by tetherin | Q27664987 | ||
| Structural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release | Q27665937 | ||
| Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells | Q28384647 | ||
| Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane | Q28472771 | ||
| Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction | Q28478446 | ||
| Mechanism of HIV-1 virion entrapment by tetherin | Q28534707 | ||
| Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology | Q28580409 | ||
| Counteraction of the multifunctional restriction factor tetherin | Q28659945 | ||
| Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu | Q29547836 | ||
| The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein | Q29619540 | ||
| The BAR domain superfamily: membrane-molding macromolecules | Q30014845 | ||
| The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract. | Q30235334 | ||
| Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase. | Q30376050 | ||
| Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. | Q30382590 | ||
| Influenza antivirals currently in late-phase clinical trial | Q30398099 | ||
| Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking | Q33455505 | ||
| Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment | Q33553369 | ||
| Dimerization of the transmembrane domain of human tetherin in membrane mimetic environments | Q45093134 | ||
| B49, a BST-2-based peptide, inhibits adhesion and growth of breast cancer cells. | Q52663561 | ||
| Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation | Q57275870 | ||
| Tetherin: Holding On and Letting Go | Q58668771 | ||
| Modulation of the NF-κB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism | Q59352162 | ||
| High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2 | Q84581960 | ||
| Porcine reproductive and respiratory syndrome virus counteracts the porcine intrinsic virus restriction factors-IFITM1 and Tetherin in MARC-145 cells | Q38968050 | ||
| Respiratory RNA Viruses | Q38977783 | ||
| BST-2 restricts IAV release and is countered by the viral M2 protein. | Q39021012 | ||
| BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface | Q39034818 | ||
| BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus | Q39062893 | ||
| Antiviral Treatments | Q39118405 | ||
| The molecular basis for differential type I interferon signaling | Q39176574 | ||
| Stimulation of NF-κB activity by the HIV restriction factor BST2. | Q39230459 | ||
| Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses. | Q39243642 | ||
| Release of filamentous and spherical influenza A virus is not restricted by tetherin | Q39409944 | ||
| Budding capability of the influenza virus neuraminidase can be modulated by tetherin | Q39611736 | ||
| HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment | Q39696123 | ||
| Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein | Q39801517 | ||
| Cooperation of the Ebola proteins VP40 and GP1,2 with BST2 to activate NF-κβ independently of virus-like particle trapping. | Q40040462 | ||
| Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season | Q40089214 | ||
| Tetherin antagonism by V proteins is a common trait among the genus Rubulavirus | Q40217772 | ||
| Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal | Q40359568 | ||
| Human parainfluenza virus type 2 V protein inhibits and antagonizes tetherin | Q40868468 | ||
| Ig-like transcript 7, but not bone marrow stromal cell antigen 2 (also known as HM1.24, tetherin, or CD317), modulates plasmacytoid dendritic cell function in primary human blood leukocytes. | Q41544565 | ||
| Retroviral retention activates a Syk-dependent HemITAM in human tetherin. | Q41743410 | ||
| Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness. | Q41922217 | ||
| Role of viral infections in the development and exacerbation of asthma in children | Q41922224 | ||
| Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human Cells | Q41927179 | ||
| Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons | Q42010307 | ||
| A novel peptide to disrupt the interaction of BST-2 and Vpu. | Q42228500 | ||
| Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin | Q42979548 | ||
| The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin | Q33564429 | ||
| Interplay between ovine bone marrow stromal cell antigen 2/tetherin and endogenous retroviruses | Q33826655 | ||
| CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection | Q33826740 | ||
| BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1) | Q33861091 | ||
| Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells | Q33862227 | ||
| Tetherin inhibits HIV-1 release by directly tethering virions to cells | Q34019962 | ||
| IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway | Q34256897 | ||
| Antagonism to human BST-2/tetherin by Sendai virus glycoproteins | Q34331538 | ||
| Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFN-dependent tetherin expression in infected cells | Q34405097 | ||
| Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities | Q34426491 | ||
| Nef proteins from simian immunodeficiency viruses are tetherin antagonists. | Q34658653 | ||
| A rare missense variant abrogates the signaling activity of tetherin/BST-2 without affecting its effect on virus release | Q34929498 | ||
| Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection | Q35076983 | ||
| Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells | Q35690771 | ||
| The tetherin/BST-2 coiled-coil ectodomain mediates plasma membrane microdomain localization and restriction of particle release | Q35826562 | ||
| Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling | Q35826825 | ||
| Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection | Q35840924 | ||
| Influenza virus partially counteracts restriction imposed by tetherin/BST-2. | Q36052469 | ||
| HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3. | Q36080904 | ||
| Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference | Q36281167 | ||
| A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2. | Q36376142 | ||
| IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN. | Q36463634 | ||
| 2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation | Q36646086 | ||
| Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children | Q36915476 | ||
| Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. | Q37115285 | ||
| The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma | Q37244199 | ||
| HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin | Q37257389 | ||
| Tetherin is an exosomal tether | Q37276774 | ||
| Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin | Q37385830 | ||
| Modulation of an ectodomain motif in the influenza A virus neuraminidase alters tetherin sensitivity and results in virus attenuation in vivo | Q37658537 | ||
| BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor | Q38070284 | ||
| Human parainfluenza virus type 2 V protein inhibits induction of tetherin | Q38813353 | ||
| Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism. | Q38823675 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| respiratory tract infection | Q754447 | ||
| P304 | page(s) | e1800086 | |
| P577 | publication date | 2018-08-16 | |
| 2018-10-01 | |||
| P1433 | published in | BioEssays | Q4914614 |
| P1476 | title | Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps | |
| P478 | volume | 40 |
Search more.